Skip to main content
Signal8

Winkler Matthew

SEC insider (Form 3/4/5 filer). CIK 0001652067. Director at Akoya Biosciences, Inc. (AKYA). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 8, 2025. Located in MARLBOROUGH, MA.

Companies Winkler Matthew has filed insider reports for

  • Akoya Biosciences, Inc. (AKYA): Director
Winkler Matthew profile photo

Winkler Matthew

CIK: 0001652067

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Akoya Biosciences, Inc. logo
AKYA

Akoya Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Direct
    984.5K shares-

1-1 of 1